Text2CT: Towards 3D CT Volume Generation from Free-text Descriptions Using Diffusion Model

Generating 3D CT volumes from descriptive free-text inputs presents a transformative opportunity in diagnostics and research. In this paper, we introduce Text2CT, a novel approach for synthesizing 3D CT volumes from textual descriptions using the diffusion model. Unlike previous methods that rely on fixed-format text input, Text2CT employs a novel prompt formulation that enables generation from diverse, free-text descriptions. The proposed framework encodes medical text into latent representations and decodes them into high-resolution 3D CT scans, effectively bridging the gap between semantic text inputs and detailed volumetric representations in a unified 3D framework. Our method demonstrates superior performance in preserving anatomical fidelity and capturing intricate structures as described in the input text. Extensive evaluations show that our approach achieves state-of-the-art results, offering promising potential applications in diagnostics, and data augmentation.

MedSegFactory: Text-Guided Generation of Medical Image-Mask Pairs

This paper presents MedSegFactory, a versatile medical synthesis framework that generates high-quality paired medical images and segmentation masks across modalities and tasks. It aims to serve as an unlimited data repository, supplying image-mask pairs to enhance existing segmentation tools. The core of MedSegFactory is a dual-stream diffusion model, where one stream synthesizes medical images and the other generates corresponding segmentation masks. To ensure precise alignment between image-mask pairs, we introduce Joint Cross-Attention (JCA), enabling a collaborative denoising paradigm by dynamic cross-conditioning between streams. This bidirectional interaction allows both representations to guide each other's generation, enhancing consistency between generated pairs. MedSegFactory unlocks on-demand generation of paired medical images and segmentation masks through user-defined prompts that specify the target labels, imaging modalities, anatomical regions, and pathological conditions, facilitating scalable and high-quality data generation. This new paradigm of medical image synthesis enables seamless integration into diverse medical imaging workflows, enhancing both efficiency and accuracy. Extensive experiments show that MedSegFactory generates data of superior quality and usability, achieving competitive or state-of-the-art performance in 2D and 3D segmentation tasks while addressing data scarcity and regulatory constraints.

Machine Learning Fleet Efficiency: Analyzing and Optimizing Large-Scale Google TPU Systems with ML Productivity Goodput

Recent years have seen the emergence of machine learning (ML) workloads deployed in warehouse-scale computing (WSC) settings, also known as ML fleets. As the computational demands placed on ML fleets have increased due to the rise of large models and growing demand for ML applications, it has become increasingly critical to measure and improve the efficiency of such systems. However, there is not yet an established methodology to characterize ML fleet performance and identify potential performance optimizations accordingly. This paper presents a large-scale analysis of an ML fleet based on Google's TPUs, introducing a framework to capture fleet-wide efficiency, systematically evaluate performance characteristics, and identify optimization strategies for the fleet. We begin by defining an ML fleet, outlining its components, and analyzing an example Google ML fleet in production comprising thousands of accelerators running diverse workloads. Our study reveals several critical insights: first, ML fleets extend beyond the hardware layer, with model, data, framework, compiler, and scheduling layers significantly impacting performance; second, the heterogeneous nature of ML fleets poses challenges in characterizing individual workload performance; and third, traditional utilization-based metrics prove insufficient for ML fleet characterization. To address these challenges, we present the "ML Productivity Goodput" (MPG) metric to measure ML fleet efficiency. We show how to leverage this metric to characterize the fleet across the ML system stack. We also present methods to identify and optimize performance bottlenecks using MPG, providing strategies for managing warehouse-scale ML systems in general. Lastly, we demonstrate quantitative evaluations from applying these methods to a real ML fleet for internal-facing Google TPU workloads, where we observed tangible improvements.

How Well Do Supervised 3D Models Transfer to Medical Imaging Tasks?

The pre-training and fine-tuning paradigm has become prominent in transfer learning. For example, if the model is pre-trained on ImageNet and then fine-tuned to PASCAL, it can significantly outperform that trained on PASCAL from scratch. While ImageNet pre-training has shown enormous success, it is formed in 2D, and the learned features are for classification tasks; when transferring to more diverse tasks, like 3D image segmentation, its performance is inevitably compromised due to the deviation from the original ImageNet context. A significant challenge lies in the lack of large, annotated 3D datasets rivaling the scale of ImageNet for model pre-training. To overcome this challenge, we make two contributions. Firstly, we construct AbdomenAtlas 1.1 that comprises 9,262 three-dimensional computed tomography (CT) volumes with high-quality, per-voxel annotations of 25 anatomical structures and pseudo annotations of seven tumor types. Secondly, we develop a suite of models that are pre-trained on our AbdomenAtlas 1.1 for transfer learning. Our preliminary analyses indicate that the model trained only with 21 CT volumes, 672 masks, and 40 GPU hours has a transfer learning ability similar to the model trained with 5,050 (unlabeled) CT volumes and 1,152 GPU hours. More importantly, the transfer learning ability of supervised models can further scale up with larger annotated datasets, achieving significantly better performance than preexisting pre-trained models, irrespective of their pre-training methodologies or data sources. We hope this study can facilitate collective efforts in constructing larger 3D medical datasets and more releases of supervised pre-trained models.

RadGPT: Constructing 3D Image-Text Tumor Datasets

With over 85 million CT scans performed annually in the United States, creating tumor-related reports is a challenging and time-consuming task for radiologists. To address this need, we present RadGPT, an Anatomy-Aware Vision-Language AI Agent for generating detailed reports from CT scans. RadGPT first segments tumors, including benign cysts and malignant tumors, and their surrounding anatomical structures, then transforms this information into both structured reports and narrative reports. These reports provide tumor size, shape, location, attenuation, volume, and interactions with surrounding blood vessels and organs. Extensive evaluation on unseen hospitals shows that RadGPT can produce accurate reports, with high sensitivity/specificity for small tumor (<2 cm) detection: 80/73% for liver tumors, 92/78% for kidney tumors, and 77/77% for pancreatic tumors. For large tumors, sensitivity ranges from 89% to 97%. The results significantly surpass the state-of-the-art in abdominal CT report generation. RadGPT generated reports for 17 public datasets. Through radiologist review and refinement, we have ensured the reports' accuracy, and created the first publicly available image-text 3D medical dataset, comprising over 1.8 million text tokens and 2.7 million images from 9,262 CT scans, including 2,947 tumor scans/reports of 8,562 tumor instances. Our reports can: (1) localize tumors in eight liver sub-segments and three pancreatic sub-segments annotated per-voxel; (2) determine pancreatic tumor stage (T1-T4) in 260 reports; and (3) present individual analyses of multiple tumors--rare in human-made reports. Importantly, 948 of the reports are for early-stage tumors.

ScaleMAI: Accelerating the Development of Trusted Datasets and AI Models

Building trusted datasets is critical for transparent and responsible Medical AI (MAI) research, but creating even small, high-quality datasets can take years of effort from multidisciplinary teams. This process often delays AI benefits, as human-centric data creation and AI-centric model development are treated as separate, sequential steps. To overcome this, we propose ScaleMAI, an agent of AI-integrated data curation and annotation, allowing data quality and AI performance to improve in a self-reinforcing cycle and reducing development time from years to months. We adopt pancreatic tumor detection as an example. First, ScaleMAI progressively creates a dataset of 25,362 CT scans, including per-voxel annotations for benign/malignant tumors and 24 anatomical structures. Second, through progressive human-in-the-loop iterations, ScaleMAI provides Flagship AI Model that can approach the proficiency of expert annotators (30-year experience) in detecting pancreatic tumors. Flagship Model significantly outperforms models developed from smaller, fixed-quality datasets, with substantial gains in tumor detection (+14%), segmentation (+5%), and classification (72%) on three prestigious benchmarks. In summary, ScaleMAI transforms the speed, scale, and reliability of medical dataset creation, paving the way for a variety of impactful, data-driven applications.

Text-Driven Tumor Synthesis

Tumor synthesis can generate examples that AI often misses or over-detects, improving AI performance by training on these challenging cases. However, existing synthesis methods, which are typically unconditional -- generating images from random variables -- or conditioned only by tumor shapes, lack controllability over specific tumor characteristics such as texture, heterogeneity, boundaries, and pathology type. As a result, the generated tumors may be overly similar or duplicates of existing training data, failing to effectively address AI's weaknesses. We propose a new text-driven tumor synthesis approach, termed TextoMorph, that provides textual control over tumor characteristics. This is particularly beneficial for examples that confuse the AI the most, such as early tumor detection (increasing Sensitivity by +8.5%), tumor segmentation for precise radiotherapy (increasing DSC by +6.3%), and classification between benign and malignant tumors (improving Sensitivity by +8.2%). By incorporating text mined from radiology reports into the synthesis process, we increase the variability and controllability of the synthetic tumors to target AI's failure cases more precisely. Moreover, TextoMorph uses contrastive learning across different texts and CT scans, significantly reducing dependence on scarce image-report pairs (only 141 pairs used in this study) by leveraging a large corpus of 34,035 radiology reports. Finally, we have developed rigorous tests to evaluate synthetic tumors, including Text-Driven Visual Turing Test and Radiomics Pattern Analysis, showing that our synthetic tumors is realistic and diverse in texture, heterogeneity, boundaries, and pathology.

Touchstone Benchmark: Are We on the Right Way for Evaluating AI Algorithms for Medical Segmentation?

How can we test AI performance? This question seems trivial, but it isn't. Standard benchmarks often have problems such as in-distribution and small-size test sets, oversimplified metrics, unfair comparisons, and short-term outcome pressure. As a consequence, good performance on standard benchmarks does not guarantee success in real-world scenarios. To address these problems, we present Touchstone, a large-scale collaborative segmentation benchmark of 9 types of abdominal organs. This benchmark is based on 5,195 training CT scans from 76 hospitals around the world and 5,903 testing CT scans from 11 additional hospitals. This diverse test set enhances the statistical significance of benchmark results and rigorously evaluates AI algorithms across various out-of-distribution scenarios. We invited 14 inventors of 19 AI algorithms to train their algorithms, while our team, as a third party, independently evaluated these algorithms on three test sets. In addition, we also evaluated pre-existing AI frameworks--which, differing from algorithms, are more flexible and can support different algorithms--including MONAI from NVIDIA, nnU-Net from DKFZ, and numerous other open-source frameworks. We are committed to expanding this benchmark to encourage more innovation of AI algorithms for the medical domain.

Label Critic: Design Data Before Models

As medical datasets rapidly expand, creating detailed annotations of different body structures becomes increasingly expensive and time-consuming. We consider that requesting radiologists to create detailed annotations is unnecessarily burdensome and that pre-existing AI models can largely automate this process. Following the spirit don't use a sledgehammer on a nut, we find that, rather than creating annotations from scratch, radiologists only have to review and edit errors if the Best-AI Labels have mistakes. To obtain the Best-AI Labels among multiple AI Labels, we developed an automatic tool, called Label Critic, that can assess label quality through tireless pairwise comparisons. Extensive experiments demonstrate that, when incorporated with our developed Image-Prompt pairs, pre-existing Large Vision-Language Models (LVLM), trained on natural images and texts, achieve 96.5% accuracy when choosing the best label in a pair-wise comparison, without extra fine-tuning. By transforming the manual annotation task (30-60 min/scan) into an automatic comparison task (15 sec/scan), we effectively reduce the manual efforts required from radiologists by an order of magnitude. When the Best-AI Labels are sufficiently accurate (81% depending on body structures), they will be directly adopted as the gold-standard annotations for the dataset, with lower-quality AI Labels automatically discarded. Label Critic can also check the label quality of a single AI Label with 71.8% accuracy when no alternatives are available for comparison, prompting radiologists to review and edit if the estimated quality is low (19% depending on body structures).

Analyzing Tumors by Synthesis

Computer-aided tumor detection has shown great potential in enhancing the interpretation of over 80 million CT scans performed annually in the United States. However, challenges arise due to the rarity of CT scans with tumors, especially early-stage tumors. Developing AI with real tumor data faces issues of scarcity, annotation difficulty, and low prevalence. Tumor synthesis addresses these challenges by generating numerous tumor examples in medical images, aiding AI training for tumor detection and segmentation. Successful synthesis requires realistic and generalizable synthetic tumors across various organs. This chapter reviews AI development on real and synthetic data and summarizes two key trends in synthetic data for cancer imaging research: modeling-based and learning-based approaches. Modeling-based methods, like Pixel2Cancer, simulate tumor development over time using generic rules, while learning-based methods, like DiffTumor, learn from a few annotated examples in one organ to generate synthetic tumors in others. Reader studies with expert radiologists show that synthetic tumors can be convincingly realistic. We also present case studies in the liver, pancreas, and kidneys reveal that AI trained on synthetic tumors can achieve performance comparable to, or better than, AI only trained on real data. Tumor synthesis holds significant promise for expanding datasets, enhancing AI reliability, improving tumor detection performance, and preserving patient privacy.